Methyl 4-(6-methyl-5,11-dioxoindeno[1,2-c]isoquinolin-3-yl)butanoate | 1426997-88-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: Methyl 4-(6-methyl-5,11-dioxoindeno[1,2-c]isoquinolin-3-yl)butanoate
• 英文别名: methyl 4-(6-methyl-5,11-dioxoindeno[1,2-c]isoquinolin-3-yl)butanoate
• CAS: 1426997-88-7
• 化学式: C₂₂H₁₉NO₄
• 分子量: 361.397
• InChiKey: IWIASIUVOGDMMF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  63.7
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  Methyl 4-(6-methyl-5,11-dioxoindeno[1,2-c]isoquinolin-3-yl)butanoate 在 水 、 potassium hydroxide 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 12.0h， 以51%的产率得到4-(6-Methyl-5,11-dioxoindeno[1,2-c]isoquinolin-3-yl)butanoic acid
  参考文献：
  名称：

  Design, Synthesis, and Biological Evaluation of Indenoisoquinoline Rexinoids with Chemopreventive Potential

  摘要：

  Nuclear receptors, such as the retinoid X receptor (RXR), are proteins that regulate a myriad of cellular processes. Molecules that function as RXR agonists are of special interest for the prevention and control of carcinogenesis. The majority of these ligands possess an acidic moiety that is believed to be key for RXR activation. This communication presents the design, synthesis, and biological evaluation of both acidic and nonacidic indenoisoquinolines as new RXR ligands. In addition, a comprehensive structure-activity relationship study is presented that identifies the important features of the indenoisoquinoline rexinoids. The ease of modification of the indenoisoquinoline core and the lack of the necessity of a carboxyl group for activity make them an attractive and unusual family of RXR agonists. This work establishes a structural foundation for the design of new and novel rexinoid cancer chemopreventive agents.

  DOI：

  10.1021/jm400026k
• 作为产物：
  描述：

  3-amino-6-methyl-5H-indeno[1,2-c]isoquinoline-5,11(6H)-dione 在 四丁基溴化铵 、 氢碘酸 、 palladium diacetate 、 potassium carbonate 、 二甲基亚砜 、 sodium nitrite 作用下， 以 1,4-二氧六环 、 水 、 N,N-二甲基甲酰胺 为溶剂， -78.0~90.0 ℃ 、344.75 kPa 条件下， 反应 28.5h， 生成 Methyl 4-(6-methyl-5,11-dioxoindeno[1,2-c]isoquinolin-3-yl)butanoate
  参考文献：
  名称：

  Design, Synthesis, and Biological Evaluation of Indenoisoquinoline Rexinoids with Chemopreventive Potential

  摘要：

  Nuclear receptors, such as the retinoid X receptor (RXR), are proteins that regulate a myriad of cellular processes. Molecules that function as RXR agonists are of special interest for the prevention and control of carcinogenesis. The majority of these ligands possess an acidic moiety that is believed to be key for RXR activation. This communication presents the design, synthesis, and biological evaluation of both acidic and nonacidic indenoisoquinolines as new RXR ligands. In addition, a comprehensive structure-activity relationship study is presented that identifies the important features of the indenoisoquinoline rexinoids. The ease of modification of the indenoisoquinoline core and the lack of the necessity of a carboxyl group for activity make them an attractive and unusual family of RXR agonists. This work establishes a structural foundation for the design of new and novel rexinoid cancer chemopreventive agents.

  DOI：

  10.1021/jm400026k

文献信息

• Design, Synthesis, and Biological Evaluation of Indenoisoquinoline Rexinoids with Chemopreventive Potential
  作者：Martin Conda-Sheridan、Eun-Jung Park、Daniel E. Beck、P. V. Narasimha Reddy、Trung X. Nguyen、Bingjie Hu、Lian Chen、Jerry J. White、Richard B. van Breemen、John M. Pezzuto、Mark Cushman

  DOI：10.1021/jm400026k

  日期：2013.3.28

  Nuclear receptors, such as the retinoid X receptor (RXR), are proteins that regulate a myriad of cellular processes. Molecules that function as RXR agonists are of special interest for the prevention and control of carcinogenesis. The majority of these ligands possess an acidic moiety that is believed to be key for RXR activation. This communication presents the design, synthesis, and biological evaluation of both acidic and nonacidic indenoisoquinolines as new RXR ligands. In addition, a comprehensive structure-activity relationship study is presented that identifies the important features of the indenoisoquinoline rexinoids. The ease of modification of the indenoisoquinoline core and the lack of the necessity of a carboxyl group for activity make them an attractive and unusual family of RXR agonists. This work establishes a structural foundation for the design of new and novel rexinoid cancer chemopreventive agents.